Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with Clostridium difficile disease

Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with Clostridium difficile disease

US Patent 10295536 · Granted May 21, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infe2019
Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infe2019
Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infe2019
Nucleic acid extraction using organic solvents to remove inhibitors2019
Nucleic acid extraction using organic solvents to remove inhibitors2019
Nucleic acid extraction using organic solvents to remove inhibitors2016
Nucleic acid extraction using organic solvents to remove inhibitors2016
Outer membrane protein 18 as a diagnostic marker for campylobacter2016
Outer membrane protein 18 as a diagnostic marker for campylobacter2016
Device and method for detection of analytes2016
Device and method for detection of analytes2016
Device and method for detection of analytes2016